Page last updated: 2024-10-18

dalteparin and Haemophilus Infections

dalteparin has been researched along with Haemophilus Infections in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Haemophilus Infections: Infections with bacteria of the genus HAEMOPHILUS.

Research Excerpts

ExcerptRelevanceReference
"A diagnosis of cavernous sinus thrombosis was made based on clinical findings and confirmed by imaging in both patients."1.33Septic thrombosis of the cavernous sinus: two different mechanisms. ( Looi, A; Pavlovich, P; Rootman, J, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pavlovich, P1
Looi, A1
Rootman, J1

Other Studies

1 other study available for dalteparin and Haemophilus Infections

ArticleYear
Septic thrombosis of the cavernous sinus: two different mechanisms.
    Orbit (Amsterdam, Netherlands), 2006, Volume: 25, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Cavernous Sinus Thrombosis; Drug Therapy, Combination;

2006